Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma. | J Oncol | 2021 | 34484330 | PubTator, text mining | PubMed |
| Association of HLA-DPA1, HLA-DPB1, and HLA-DQB1 Alleles With the Long-Term and Booster Immune Responses of Young Adults Vaccinated Against the Hepatitis B Virus as Neonates. | Front Immunol | 2021 | 34484213 | PubTator, text mining | PubMed |
| A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis. | Front Immunol | 2021 | 34484194 | PubTator, text mining | PubMed |
| Influencing Factors of the Continuous Usage Intention of Consumers of Online Food Delivery Platform Based on an Information System Success Model. | Front Psychol | 2021 | 34484080 | PubTator, text mining | PubMed |
| Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of Cryptococcus neoformans var. grubii. | J Immunol Res | 2021 | 34471644 | PubTator, text mining | PubMed |
| PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 34470916 | PubTator, text mining | PubMed |
| Spectral and time-resolved photoluminescence of human platelets doped with platinum nanoparticles. | PLoS One | 2021 | 34469464 | PubTator, text mining | PubMed |
| Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. | Science | 2021 | 34465633 | PubTator, text mining | PubMed |
| Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer. | Aging (Albany NY) | 2021 | 34461608 | PubTator, text mining | PubMed |
| Impact of HLA type, age and chronic viral infection on peripheral T-cell receptor sharing between unrelated individuals. | PLoS One | 2021 | 34460826 | PubTator, text mining | PubMed |
| Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma. | Clin Transl Med | 2021 | 34459128 | PubTator, text mining | PubMed |
| A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma. | Thorac Cancer | 2021 | 34453499 | PubTator, text mining | PubMed |
| Spatially organized multicellular immune hubs in human colorectal cancer. | Cell | 2021 | 34450029 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer's Disease. | Front Immunol | 2021 | 34447367 | PubTator, text mining | PubMed |
| Disparity of Hepatocellular Carcinoma in Tumor Microenvironment-Related Genes and Infiltrating Immune Cells between Asian and Non-Asian Populations. | Genes (Basel) | 2021 | 34440448 | PubTator, text mining | PubMed |
| Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer. | Cancers (Basel) | 2021 | 34439181 | PubTator, text mining | PubMed |
| MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. | J Clin Lab Anal | 2021 | 34432318 | PubTator, text mining | PubMed |
| Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese. | J Hepatocell Carcinoma | 2021 | 34430511 | PubTator, text mining | PubMed |
| SMOX expression predicts the prognosis of non-small cell lung cancer. | Ann Transl Med | 2021 | 34422960 | PubTator, text mining | PubMed |
| Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer. | Aging (Albany NY) | 2021 | 34413268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=59